Gene-editing therapies—techniques that modify DNA to treat or prevent disease—have the potential to transform the field of ...

CRISPR genome editing is revolutionizing medicine. Rapid market growth, fueled by startups and new therapies, brings ethical ...

UCSB Arts & Lectures and the Cancer Foundation of Santa Barbara host the Nobel Prize–winning biochemist for a talk on CRISPR ...

Scientists at Colossal Biosciences may be a few steps closer to resurrecting a long-extinct carnivorous marsupial known as ...

CRISPR technology allows for precise DNA modifications, holding promise for treating genetic disorders and revolutionizing ...

CAMBRIDGE, Mass. and VANCOUVER, British Columbia and BASEL, Switzerland, Oct. 21, 2024 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: ...

A collaborative effort between investigators at the National Institutes of Health's National Institute of Allergy and ...

Two public companies focused on RNA editing therapies, Korro Bio and ProQR, enjoyed impressive stock surges powered by their best-ever one day gains; their share prices lifted by Wave Life Sciences ...

A team of scientists at the University of Illinois discovered naturally-occurring DNA-protein hybrid molecules last ...

Wave Life Sciences' alpha-1 antitrypsin deficiency candidate WVE-006 succeeded in the first-ever clinical demonstration of ...

Colossal Biosciences, which intends to create proxy species of the woolly mammoth, dodo, and Tasmanian tiger, claims it has ...

HuidaGene Therapeutics ("HuidaGene"), a global clinical-stage biotechnology company pioneering CRISPR-based programmable genome medicines, today announced the appointment of Dr. TJ Cradick as Chief ...